The next major case in a consolidated Xarelto blood thinner lawsuit will rely on expert witness testimony from physicians. The prescribing physicians’ testimony is expected to be very influential in the outcome of this second Philadelphia blood thinner lawsuit.
This is not the first time that a physician’s insight will be influential in the case outcome. Industry advocates and lawyers believe that the previous physician’s input that knowledge of the bleeding risks wouldn’t have altered the prescription choice was seen as a big blow to the plaintiff’s allegations.
The defendants have already achieved success with the first of their three bellwether cases and one plaintiff ‘s win was reversed in favor of the defendants in one of the many claims included in the blood thinner lawsuit currently being managed in Philadelphia.
Three new blood thinner lawsuit claims are scheduled to begin in Philadelphia next month and the defendants are also requesting that the plaintiffs not be allowed to amend their master complaint in the mass tort. The prescribing physicians’ testimony is anticipated to be key in how the next Xarelto blood thinner lawsuit outcome comes about.
Another case involved throwing out a $28 million verdict because of testimony that the bleeding risks associated with wouldn’t have changed that doctor’s prescription choice.
However, the new lawsuit includes similar claims against the manufacturers of the drug, accusing the drug’s makers of failing to include an unambiguous, sufficiently forceful or clear warning about the high risk of bleeding.
Many of these patients have come forward to file a lawsuit and those claims have been consolidated in Philadelphia.
It is anticipated that the physician testimony in future cases will be critically important for determining whether or not plaintiffs will be able to recover damages and show that the manufacturer was responsible in the blood thinner lawsuit.
Since bleeding risks are common with many drugs similar to , prescribing physicians will need to explain how the lack of awareness about the high risk of internal bleeding with did or did not affect their decision.
Plaintiffs and experts in this Xarelto blood thinner lawsuit will need to show that the severe bleeding risks associated with were much more serious than advertised or explained by the company in order to continue with their claims that the manufacturer failed to paint an accurate picture..
Many patients who have experienced sudden and life-threatening bleeding explain that they were never fully told about these risks when being given the medication and argue that their doctors may not have prescribed the medication if they had known about the dangers.
The Xarelto Blood Thinner Lawsuit is Case No. 150500362, in the Court of Common Pleas of Philadelphia County, Pennsylvania.
Patients who have been significantly affected by unexpected internal bleeding after using following a doctor’s prescription may be eligible to pursue compensation in a legal case. Consulting with the experienced attorneys at McDonald Worley is strongly recommended.
Disclaimer: McDonald Worley is not representing the plaintiff in this lawsuit.